chevron_leftBack
As of 13 June 2026, Bio Essence Corp. has a market cap of $19.65M USD, ranking #37192 globally and #5006 in the United States.
It ranks #3338 in the Healthcare sector, and #208 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$19.65MUSD
Enterprise Value
$21.21MUSD
Revenue (TTM)
$1.9MUSD
EBITDA (TTM)
$900.25KUSD
Net Income (TTM)
$896.2KUSD
EBITDA Margin
47%
Profit Margin
47%
PE Ratio
21.9
PS Ratio
10.4
PB Ratio
-9.5
EV/EBITDA
22.5
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Yin Yan
open_in_new
Employees
2
Founded
2000
Website
bioessencecorp.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 15% | 0% | 165% | 782% | 555% | 118% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
BIOE
Bio Essence Corp
ISIN: US09090C1053
Shares Out.:
Shares Outstanding:
46.809M1
Shares Float:
12.413M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.5170 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Bio Essence Corp.
Bio Essence Corporation engages in the manufacturing and distributing health supplement products. It also offers original equipment manufacturing services. Bio Essence Corporation was incorporated in 2000 and is headquartered in Irvine, California.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: RVMD
|
$29.56B
150K%
|
-
|
|
LSE: INDV
|
$2.07B
10K%
1.54B GBP
|
-
|
|
OTCMKTS: NDOI
|
$1.8B
9K%
|
0.4
|
|
NASDAQ: DVAX
|
$1.76B
9K%
|
-
|
|
NASDAQ: AVBP
|
$1.33B
7K%
|
-
|
|
NYSE: BRBR
|
$1.02B
5K%
|
12.1
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$36.75B
187K%
108.92B ILS
|
24.2
|
|
SHE: 002001
|
$15.84B
81K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.16B
57K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.04B
56K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.09B
46K%
61.6B CNY
|
80.6
|
|
EPA: ABVX
|
$8.74B
44K%
7.57B EUR
|
-
|
chevron_leftBack